top of page

Mwandishi

Mhariri:

Imeboreshwa:

< Orodha kuu

ULY CLINIC

ULY CLINIC

Jumanne, 14 Julai 2026, 12:55:47 UTC

Pseudomembranous colitis management

Pseudomembranous colitis management

Pseudomembranous colitis is caused by Clostridium difficile, a Gram-positive anaerobic bacterium that causes antibiotic-associated diarrhea due to alteration of normal intestinal flora and release of enterotoxins.


Clinical presentation

  • Bloody diarrhea

  • Abdominal cramps and tenderness

  • Nausea

  • Fever

  • Dehydration


Investigations

  • Lower endoscopy showing characteristic pseudomembranous yellowish plaques overlying ulcerated and friable rectosigmoid colonic mucosa

  • Laboratory evidence of C. difficile toxin A/B:

    • Stool toxin assay (Toxin B)

    • ELISA assay (Toxin A)


Pharmacological treatment


Discontinue causative antibiotic

Stop the suspected precipitating antibiotic whenever possible.


Antimicrobial therapy

Metronidazole

  • Metronidazole (PO) 400 mg 8 hourly for 10–14 days

OR

Vancomycin

  • Vancomycin (PO) Adults: 125–500 mg 6 hourly for 10–14 days


Supportive management

  • Fluid and electrolyte replacement as indicated

  • Monitor hydration status and clinical response

Note Resuscitative and supportive management should be instituted as described for ulcerative colitis. Refer to the next level of care with adequate expertise and facilities for all suspected cases requiring initial evaluation and management. Urgent referral is required for patients presenting with acute complications such as toxic megacolon.

Imeandikwa:

Jumatatu, 22 Juni 2026, 12:14:35 UTC

References:

bottom of page